A nationwide recall has been issued for specific compound GLP-1 drugs. These affected medications are neither FDA-approved nor classified as name-brand pharmaceutical products.
The recall highlights ongoing regulatory and safety concerns surrounding the availability and distribution of alternative compounded versions of popular GLP-1 medications.
Newz